Login to Your Account



CollaGenex Files NDA, Gains Patent On Oracea In Psoriasis

By Randall Osborne


Monday, August 8, 2005

The old adage - seldom spoken in our more enlightened, animal-sensitive times - about there being "more than one way to skin a cat" might have come to mind last week when CollaGenex Pharmaceuticals Inc. disclosed its plan to get around a generic threat to Periostat for gum disease.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription